IL4R and allergic asthma: We developed a TAM‐induced, conditional IL‐4Rα knockdown mouse model (RosacreERT2IL‐4Rα−/lox) and sought to investigate the temporal role of IL‐4Rα receptor signaling during the effector phase (therapeutic) and priming/sensitization phase (prophylactic) of allergic asthma.